In my opinion, the introduction of "CKD" as a disease entity has marked a significant advancement in nephrology (in terms of epidemiological studies, assessment of nephroprotective effects of drugs, and pathophysiological study of CKD of different etiology).
I believe that patients should know that they have been affected by chronic renal disease and they should tell their doctors, whatever the specialty, about the disease. Despite what the authors say, CKD patients should be referred to nephrologists because they have the best experience in the treatment of the disease according to current medical knowledge. The authors seem to be unaware how important it is to introduce an individualized treatment of CKD depending on numerous confounders that have not been included in numerous clinical trials. After all, the results of the trials: Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) 2 and Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage ¾ (PRIMO) 3 have shown that lack of hard evidence does not always downgrade the value of drugs because it may be caused by limitations in study design. The introduction of "CKD" minimizes the risk of unreliable results, especially in cases where they do not correspond to the clinical status of the patient.
To the Editor I have recently read an article by Prasad and Cifu, 1 in which they presented the concept of eliminating the name "chronic kidney disease" (CKD) as a diagnosis.
1 The authors do not seem to be fully aware how much clinical and epidemiological studies have benefited from the introduction of a separate disease entity of "CKD" and its individual stages. Despite what the authors stated at the beginning of their article, the entity of CKD is as old as the disease itself, and it has always had a broader meaning than just "higher creatinine levels". Furthermore, the authors state that the diagnosis of CKD itself does not really mean much for the patient because it does not affect the treatment administered by the general practitioner, and moreover, that such diagnosis necessitates an array of complex laboratory and imaging tests as well as consultations that do not clearly benefit the patient.
In my opinion, the authors are not fully aware of the fact that the diagnosis of CKD may lead to profound changes in the patient's lifestyle, diet, and physical activity, thus slowing down the progression of renal disease. It may also affect pharmacological treatment, especially in the case of comorbidities. Moreover, the diagnosis of CKD has serious implications for diagnostic procedures and treatment if the patient is consulted by physicians who are not nephrologists.
According to the authors, 1 a referral to a nephrologist is not necessary because it does not affect the treatment outcome in any way. I was also surprised by the statement that mortality is not associated with the use of erythropoietin and that nephrologists do not know target phosphate levels in patients with CKD. Moreover, the authors 1 suggested that the use of "CKD" is "disease mongering", that is, "broadening of diagnosis categories to increase the utilization of medical resources with no evidence of corresponding health benefit". I think that the authors did not have any contact with CKD patients in the times when erythropoietin was not available or when little was known on calcium-phosphate imbalance. For some reasons, the authors chose not to discuss the beneficial effects of erythropoietin and calcium-phosphate balance on patients' lives.
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